Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | alpha-amylase, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | alpha-amylase, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | alpha-amylase, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | amylase, putative | 0.0021 | 0 | 0.5 |
Loa Loa (eye worm) | alpha amylase | 0.0087 | 1 | 1 |
Trichomonas vaginalis | amylase, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | alpha-amylase, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | alpha-amylase, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | alpha-amylase, putative | 0.0021 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable alpha-glucosidase AglA (maltase) (glucoinvertase) (glucosidosucrase) (maltase-glucoamylase) (lysosomal alpha-glucosidas | 0.0087 | 1 | 1 |
Toxoplasma gondii | 1,4-alpha-glucan-branching enzyme | 0.0021 | 0 | 0.5 |
Chlamydia trachomatis | glycogen hydrolase | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | alpha glucosidase | 0.0087 | 1 | 1 |
Giardia lamblia | 1,4-alpha-glucan branching enzyme | 0.0021 | 0 | 0.5 |
Chlamydia trachomatis | 1,4-alpha-glucan branching enzyme | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | alpha-amylase, putative | 0.0021 | 0 | 0.5 |
Toxoplasma gondii | alpha amylase, catalytic domain-containing protein | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | alpha-amylase | 0.0087 | 1 | 1 |
Trichomonas vaginalis | alpha-amylase, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | alpha-amylase, putative | 0.0021 | 0 | 0.5 |
Echinococcus granulosus | alpha glucosidase | 0.0087 | 1 | 1 |
Mycobacterium ulcerans | trehalose synthase TreS | 0.0087 | 1 | 1 |
Toxoplasma gondii | glycosyltransferase | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | alpha-amylase | 0.0087 | 1 | 1 |
Trichomonas vaginalis | starch branching enzyme II, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | amylase, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | alpha-amylase, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | alpha-amylase, putative | 0.0021 | 0 | 0.5 |
Mycobacterium tuberculosis | Trehalose synthase TreS | 0.0087 | 1 | 1 |
Brugia malayi | Alpha amylase, catalytic domain containing protein | 0.0087 | 1 | 1 |
Mycobacterium leprae | Putative uncharacterized protein ML2045 | 0.0087 | 1 | 0.5 |
Loa Loa (eye worm) | alpha amylase | 0.0087 | 1 | 1 |
Trichomonas vaginalis | amylase, putative | 0.0021 | 0 | 0.5 |
Entamoeba histolytica | oligo-1,6-glucosidase, putative | 0.0087 | 1 | 1 |
Trichomonas vaginalis | alpha-amylase, putative | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | alpha-amylase | 0.0087 | 1 | 1 |
Trichomonas vaginalis | alpha-amylase, putative | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | alpha-amylase | 0.0087 | 1 | 1 |
Toxoplasma gondii | Alpha-amylase AMY3, putative | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | alpha-amylase | 0.0087 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ratio (binding) | = 0.7 /M/s | Inhibition of recombinant Plasmodium falciparum GAPDH expressed in Escherichia coli assessed as ratio of kinact to Ki by Kitz-Wilson double-reciprocal plot | ChEMBL. | 25137375 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.